BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27471094)

  • 1. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
    Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
    Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
    Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
    Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
    Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
    Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
    J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering.
    Holbourn KP; Malfois M; Acharya KR
    J Biol Chem; 2011 Jun; 286(25):22243-9. PubMed ID: 21543320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
    Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
    Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
    J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
    Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
    J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
    Peidl A; Perbal B; Leask A
    PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells.
    Minchenko DO; Kharkova AP; Tsymbal DO; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2015 Oct; 49(4):185-97. PubMed ID: 26494037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.
    MacDonald IJ; Huang CC; Liu SC; Lin YY; Tang CH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CCN, a vertebrate specific gene family, in development.
    Katsube K; Sakamoto K; Tamamura Y; Yamaguchi A
    Dev Growth Differ; 2009 Jan; 51(1):55-67. PubMed ID: 19128405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
    Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
    J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CCN family: a new stimulus package.
    Brigstock DR
    J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characteristics of CCN proteins in tumor development.
    Barreto SC; Ray A; Ag Edgar P
    J BUON; 2016; 21(6):1359-1367. PubMed ID: 28039692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival
    Kaddour N; Zhang D; Gao ZH; Liu JL
    Growth Factors; 2019 Aug; 37(3-4):120-130. PubMed ID: 31437074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.